| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.03B | 36.57B | 24.54B | 19.02B | 22.60B | 24.58B |
| Gross Profit | 4.46B | 8.59B | 4.32B | 4.82B | 4.44B | 4.14B |
| EBITDA | 1.25B | 4.74B | 1.41B | 2.68B | 1.20B | 1.13B |
| Net Income | 375.16M | 2.11B | 373.82M | 1.48B | 590.74M | 673.76M |
Balance Sheet | ||||||
| Total Assets | 18.43B | 32.11B | 17.55B | 16.82B | 14.38B | 15.37B |
| Cash, Cash Equivalents and Short-Term Investments | 3.15B | 4.00B | 2.88B | 2.90B | 3.75B | 2.88B |
| Total Debt | 9.92B | 16.12B | 9.07B | 7.67B | 7.10B | 7.56B |
| Total Liabilities | 12.55B | 24.03B | 11.64B | 11.07B | 10.00B | 11.40B |
| Stockholders Equity | 5.88B | 8.08B | 5.91B | 5.75B | 4.34B | 3.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -6.32B | -789.84M | -2.02B | 1.53B | -658.72M |
| Operating Cash Flow | 0.00 | -6.13B | 92.37M | 144.00M | 1.77B | -454.96M |
| Investing Cash Flow | 0.00 | -42.57M | -1.64B | -1.54B | -289.28M | -122.47M |
| Financing Cash Flow | 0.00 | 6.41B | 1.12B | 336.24M | -631.80M | 857.46M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥31.49B | 6.12 | ― | 3.79% | -5.36% | -24.55% | |
74 Outperform | ¥59.65B | 14.94 | ― | 2.65% | -10.26% | -21.62% | |
68 Neutral | ¥10.04B | 10.67 | ― | 2.47% | 29.24% | 96.17% | |
68 Neutral | ¥19.52B | 28.21 | ― | 2.91% | -19.58% | -50.54% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥18.30B | 7.03 | ― | 1.03% | 49.03% | 462.70% | |
53 Neutral | ¥169.78B | -61.67 | -6.21% | 1.61% | -1.34% | -107.63% |